Timothy J. Pluard, MD

Peer Reviewed Manuscripts

Adkins D, Brown R, Trinkaus K, Maziarz R, Leudke S, Freytes C, Needles B, Fracasso P, Pluard T, Moriconi W, Ryan T, Hoelzer K, Safdar S, Rearden T, Rodriguez G, Khoury H, Vij R, DiPersio J: Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer. J Clin Oncol 17:2006-2014;1999.

O'Reilly EM, Niedzwiecki D, Hall M, Hollis D, Bekaii-Saab T, Pluard T, Douglas K, Abou-Alfa GK, Kindler HL, Schilsky RL, Goldberg RM; for the Cancer and Leukemia Group B: A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma. Oncologist. 2010 Dec 10. [Epub ahead of print]

Fracasso PM, Williams KJ, Chen RC, Picus J, Ma CX, Ellis MJ, Tan BR, Pluard TJ, AdkinsDR, Naughton MJ, Rader JS, Arquette MA, Fleshman JW, Creekmore AN, Goodner SA, Wright LP, Guo Z, Ryan CE, Tao Y, Soares EM, Cai SR, Lin L, Dancey J, Rudek MA, McLeod HL, Piwnica-Worms H., A phase I study of UCN-01 in combination with irinotrecan in patients with resistant solid tumor malignancies. Cancer Chemother Pharmocol 2010 Aug 8 [ Epub ahead of print]

Aft R, Naughton M, Trinkaus K, Watson M, Ylagan L, Chavez-MacGregor M, Zhai J, Kuo S, Shannon W, Diemer K, Herrmann V, Dietz J, Ali A, Ellis M, Weiss P, Eberlein T, Ma C, Fracasso PM, Zoberi I, Taylor M, Gillanders W, Pluard T, Mortimer J, Weilbaecher K.: Effect of Zoledronic Acid on disseminated tumor cells in women with locally advanced breast cancer: an open label, randomized phase 2 trial. Lancet Oncol May; 11(5):421-8.

Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO,Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov;136(2):355-63. doi: 10.1007/s10549-011-1910-7. Epub 2012 Jan 13.

Al Mushawah F, Rastelli A, Pluard T, Margenthaler JA. Metastatic invasive breast cancer recurrence following curative-intent therapy for ductal carcinoma in situ. J Surg Res. 2012 Mar;173(1):10-5. doi: 10.1016/j.jss.2011.04.058. Epub 2011 May 23. PubMed PMID: 21696764.

Abstracts

O’Reilly EM, Niedzwiecki D, Hollis DR, Bekaii-Saab TS, Pluard T, Duffy A, Overcash F, Ivy SP, Goldberg RM. A pahse II trial of sunitinib in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603. J Clin Oncol 26:2008 (May 20 suppl; abstr 4515). 

T. A. Samuel, C. Sessa, C. Britten, K. S. Milligan, M. M. Mita, U. Banerji, T. J. Pluard, P. Stiegler, C. Quadt, G. Shapiro; A phase I dose escalation study of AUY922, a novel HSP90 inhibitor in patients with advanced solid malignancies. J Clin Oncol 27:15s, 2009 (suppl; abstr 3532)

Tan BR, Myerson R, Linehan D, Hawkins W, Pluard T, Fournier C, James J, Strasberg S, Picus J. Adjuvant gemcitabine plus docetaxel followed by 5FU chemoradiation for patients with resected pancreaticobiliary cancers: A single-institution phase II study. ASCO 2008 GastrointestinalCancers Symposium, Abstract No. 237.

Hahn OM, Ma CX, Lin L, Sattar H, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard TJ, Watson MA, Ellis M, Conzen SD, Fleming GF: A Phase II Trial of a mammalian target of rapamycin inhibitor, temsirolimus, in patients with metastatic breast cancer. SABCS, 2008 Abstract # 407

C. Sessa, S. K. Sharma, C. D. Britten, N. J. Vogelzang, K. N. Bhalla, M. M. Mita, T. J. Pluard, P. Stiegler, C. Quadt, G. I. Shapiro; A phase I dose escalation study of AUY922, a novel HSP90 inhibitor, in patients with advanced solid malignancies. ; J Clin Oncol 27:15s, 2009 (suppl; abstr 3532)

Burstein HJ, Barry WT, Cirrincione C, Chew HK, Tolaney S, Lake D, Pluard T, Blackwell K, Winer EP, Hudis CA. CALGB 40302: Fulvestrant with or without Lapatinib as Therapy for Hormone Receptor Positive Advanced Breast Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Study; Cancer Research 70(24) 109s

Roop R, Naughton M, Schneider J, Lammers P, Pluard T, Johnson F, Eby C, Weilbaecher K. Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients with Metastatic Breast Cancer: A Randomized Phase II Trial. ; Cancer Research 70(24) 250s 

Ellis M, Suman V, McCall L, Luo R, Brink A, Watson M, Ma C, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther M, Leitch M, Ota D, Olson J, Hunt K, Allred, C.: Z1031B Neoadjuvant Aromatase Inhibitor Trial: A Phase 2 study of Triage to Chemotherapy based on 2 to 4 week ki67 level >10% Presented at SABCS 2012

Invited Publications

Fine HA, Pluard TJ: Tumor angiogenesis: Biology and therapeutic implications In: Mauch P, Loeffler J, (eds.). Radiation Oncology: Theory and Practice.

Fehniger T, Welch J, Pluard T. Hematologic Malignancies: Chronic Leukemias. The Washington Manual of Oncology, 2nd edition, 319, 2008.